In exploring the regulation of prostate cancer progression by hypermethylated in cancer 1 (HIC1) through epigenetic modifications, Zheng et al. were surprised to find that substantial methylation occurred within the HIC1 promoter and directly targeted the chemokine receptor CXCR7. The gene discussed is HIC1; the disease is prostate cancer.